Comparison 1. MSD‐HSCT versus IST ‐ all patients.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Mortality | 3 | 229 | Hazard Ratio (Random, 95% CI) | 0.95 [0.43, 2.12] |
2 Secondary clonal disease or malignancies | 2 | 170 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 0.54 [0.07, 4.00] |